Difference between revisions of "Invasive ductal carcinoma of the pancreas"

Jump to navigation Jump to search
prognosticator
(prognosticator)
 
Line 22: Line 22:
| Symptoms  =
| Symptoms  =
| Prevalence = common for site
| Prevalence = common for site
| Bloodwork  =
| Bloodwork  = elevated CA19-9
| Rads      = pancreatic mass
| Rads      = pancreatic mass
| Endoscopy  =
| Endoscopy  =
Line 57: Line 57:


Clinical:
Clinical:
*Serum CA19-9 - predicts outcome.<ref name=pmid28924968>{{Cite journal  | last1 = Usón Junior | first1 = PLS. | last2 = Callegaro-Filho | first2 = D. | last3 = Bugano | first3 = DDG. | last4 = Moura | first4 = F. | last5 = Maluf | first5 = FC. | title = Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer. | journal = J Gastrointest Cancer | volume = 49 | issue = 4 | pages = 481-486 | month = Dec | year = 2018 | doi = 10.1007/s12029-017-0007-x | PMID = 28924968 }}</ref>
*Serum CA19-9 - >2504 U/ml predicts outcome.<ref name=pmid28924968>{{Cite journal  | last1 = Usón Junior | first1 = PLS. | last2 = Callegaro-Filho | first2 = D. | last3 = Bugano | first3 = DDG. | last4 = Moura | first4 = F. | last5 = Maluf | first5 = FC. | title = Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer. | journal = J Gastrointest Cancer | volume = 49 | issue = 4 | pages = 481-486 | month = Dec | year = 2018 | doi = 10.1007/s12029-017-0007-x | PMID = 28924968 }}</ref>


==Gross==  
==Gross==  
48,466

edits

Navigation menu